glp 1 meds and hashimoto's 10 Surprising Facts About GLP-1/GIP Medications in Hypothyroid Patients Why Women with Hashimoto's Are

The Phase 2 Trial Data In the key Phase 2 randomized controlled trial published in the New England Journal of Medicine in 2023 (N=338), participants receiving retatrutide 12 mg weekly lost a mean of 24.2% of body weight at 48 weeks versus 2.1% on placebo [1]

Novel mechanism of action GLP-1 drugs target appetite neurohormonal pathways in a way other weight loss drugs do not, providing a new avenue for treatment, according to ro.co.(2) Impressive weight loss results In clinical trials, GLP-1 medications have helped patients lose on average 15-20% of their starting weight over 6-12 months

Diabetol Metab Syndr 16 , 92 (2024)

Before receiving the injection, one of our GPs may consult with you to determine whether B12 treatment is clinically appropriate